Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T14:11:26.391Z.
Calculation as of: 2026-10-06T14:11:26.391Z.
Quote observation: 2026-10-06T14:09:28.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5c43800b4bbd853816ee6b6a3197f6c41b044576dc8363c8b0de1b2dfc9d5ab8
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2023-03-16.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
1.39x
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$7.06M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Co-Diagnostics, Inc. (CODX) | $6.88M | N/A | 1.39x | N/A | N/A |
| Mangoceuticals, Inc. (MGRX)vs › | $7.09M | N/A | N/A | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.36M | N/A | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.06M | N/A | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.82M | N/A | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.80M | N/A | N/A | N/A | N/A |
| HeartSciences Inc. (HSCS)vs › | $7.78M | N/A | N/A | N/A | N/A |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | N/A | N/A | N/A | N/A |
| Longeveron Inc. (LGVN)vs › | $7.46M | N/A | N/A | N/A | N/A |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.65M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2023-03-16 | 1.10x |
| 2023-03-15 | 0.95x |
| 2023-03-14 | 1.19x |
| 2023-03-13 | 0.75x |
| 2023-03-10 | 0.81x |
| 2023-03-09 | 0.87x |
| 2023-03-08 | 1.01x |
| 2023-03-07 | 0.98x |
| 2023-03-06 | 1.28x |
| 2023-03-03 | 1.31x |
| 2023-03-02 | 1.19x |
| 2023-03-01 | 0.84x |
| 2023-02-28 | 0.89x |
| 2023-02-27 | 0.84x |
| 2023-02-24 | 1.25x |
| 2023-02-23 | 1.49x |
| 2023-02-22 | 1.31x |
| 2023-02-21 | 1.13x |
| 2023-02-17 | 1.34x |
| 2023-02-16 | 1.31x |
| 2023-02-15 | 0.89x |
| 2023-02-14 | 0.75x |
| 2023-02-13 | 0.81x |
| 2023-02-10 | 0.81x |
| 2023-02-09 | 0.57x |
| 2023-02-08 | 0.75x |
| 2023-02-07 | 0.72x |
| 2023-02-06 | 0.72x |
| 2023-02-03 | 1.07x |
| 2023-02-02 | 1.67x |
| 2023-02-01 | 1.67x |
| 2023-01-31 | 1.94x |
| 2023-01-30 | 1.43x |
| 2023-01-27 | 0.89x |
| 2023-01-26 | 0.78x |
| 2023-01-25 | 0.72x |
| 2023-01-24 | 0.64x |
| 2023-01-23 | 0.92x |
| 2023-01-20 | 1.07x |
| 2023-01-19 | 0.69x |
| 2023-01-18 | 0.72x |
| 2023-01-17 | 1.40x |
| 2023-01-13 | 1.13x |
| 2023-01-12 | 0.81x |
| 2023-01-11 | 0.81x |
| 2023-01-10 | 0.60x |
| 2023-01-09 | 0.09x |
| 2023-01-04 | 0.06x |
| 2022-12-21 | 0.00x |
| 2022-12-14 | 0.00x |
| 2022-12-12 | 0.33x |
| 2022-12-09 | 0.54x |
| 2022-12-08 | 0.57x |
| 2022-12-07 | 0.89x |
| 2022-12-06 | 0.92x |
| 2022-12-05 | 1.16x |
| 2022-12-02 | 1.52x |
| 2022-12-01 | 1.40x |
| 2022-11-30 | 1.25x |
| 2022-11-29 | 1.19x |
| 2022-11-28 | 1.58x |
| 2022-11-25 | 2.17x |
| 2022-11-23 | 2.50x |
| 2022-11-22 | 2.62x |
| 2022-11-21 | 2.29x |
| 2022-11-18 | 2.41x |
| 2022-11-17 | 2.83x |
| 2022-11-16 | 2.95x |
| 2022-11-15 | 3.24x |
| 2022-11-14 | 3.21x |
| 2022-11-11 | 3.15x |
| 2022-11-10 | 0.88x |
| 2022-11-09 | 0.77x |
| 2022-11-08 | 0.97x |
| 2022-11-07 | 1.01x |
| 2022-11-04 | 0.89x |
| 2022-11-03 | 0.87x |
| 2022-11-02 | 0.94x |
| 2022-11-01 | 1.07x |
| 2022-10-31 | 0.89x |
| 2022-10-28 | 0.75x |
| 2022-10-27 | 0.58x |
| 2022-10-26 | 0.74x |
| 2022-10-25 | 0.64x |
| 2022-10-24 | 0.59x |
| 2022-10-21 | 0.58x |
| 2022-10-20 | 0.46x |
| 2022-10-19 | 0.50x |
| 2022-10-18 | 0.58x |
| 2022-10-17 | 0.48x |
| 2022-10-14 | 0.51x |
| 2022-10-13 | 0.87x |
| 2022-10-12 | 0.86x |
| 2022-10-11 | 0.73x |
| 2022-10-10 | 0.78x |
| 2022-10-07 | 0.66x |
| 2022-10-06 | 0.72x |
| 2022-10-05 | 0.75x |
| 2022-10-04 | 0.83x |
| 2022-10-03 | 0.74x |
| 2022-09-30 | 0.61x |
| 2022-09-29 | 0.58x |
| 2022-09-28 | 0.53x |
| 2022-09-27 | 0.35x |
| 2022-09-26 | 0.29x |
| 2022-09-23 | 0.41x |
| 2022-09-22 | 0.25x |
| 2022-09-21 | 0.30x |
| 2022-09-20 | 0.46x |
| 2022-09-19 | 0.55x |
| 2022-09-16 | 0.63x |
| 2022-09-15 | 0.64x |
| 2022-09-14 | 0.70x |
| 2022-09-13 | 0.51x |
| 2022-09-12 | 0.71x |
| 2022-09-09 | 0.68x |
| 2022-09-08 | 0.64x |
| 2022-09-07 | 0.56x |
| 2022-09-06 | 0.47x |
| 2022-09-02 | 0.58x |
| 2022-09-01 | 0.59x |
| 2022-08-31 | 0.79x |
| 2022-08-30 | 0.97x |
| 2022-08-29 | 0.94x |
| 2022-08-26 | 0.97x |
| 2022-08-25 | 1.08x |
| 2022-08-24 | 1.04x |
| 2022-08-23 | 1.03x |
| 2022-08-22 | 1.07x |
| 2022-08-19 | 1.15x |
| 2022-08-18 | 1.20x |
| 2022-08-17 | 1.31x |
| 2022-08-16 | 1.57x |
| 2022-08-15 | 1.78x |
| 2022-08-12 | 1.97x |
| 2022-08-11 | 2.76x |
| 2022-08-10 | 2.89x |
| 2022-08-09 | 2.67x |
| 2022-08-08 | 3.18x |
| 2022-08-05 | 3.02x |
| 2022-08-04 | 3.03x |
| 2022-08-03 | 2.84x |
| 2022-08-02 | 2.86x |
| 2022-08-01 | 2.88x |
| 2022-07-29 | 2.84x |
| 2022-07-28 | 2.69x |
| 2022-07-27 | 2.41x |
| 2022-07-26 | 2.46x |
| 2022-07-25 | 2.46x |
| 2022-07-22 | 2.21x |
| 2022-07-21 | 2.47x |
| 2022-07-20 | 2.50x |
| 2022-07-19 | 2.35x |
| 2022-07-18 | 2.24x |
| 2022-07-15 | 2.25x |
| 2022-07-14 | 2.29x |
| 2022-07-13 | 2.37x |
| 2022-07-12 | 2.29x |
| 2022-07-11 | 2.52x |
| 2022-07-08 | 2.40x |
| 2022-07-07 | 2.53x |
| 2022-07-06 | 2.37x |
| 2022-07-05 | 2.51x |
| 2022-07-01 | 2.30x |
| 2022-06-30 | 2.12x |
| 2022-06-29 | 1.94x |
| 2022-06-28 | 1.73x |
| 2022-06-27 | 1.91x |
| 2022-06-24 | 1.97x |
| 2022-06-23 | 2.03x |
| 2022-06-22 | 1.82x |
| 2022-06-21 | 1.76x |
| 2022-06-17 | 1.78x |
| 2022-06-16 | 1.79x |
| 2022-06-15 | 1.94x |
| 2022-06-14 | 1.79x |
| 2022-06-13 | 1.69x |
| 2022-06-10 | 1.73x |
| 2022-06-09 | 1.95x |
| 2022-06-08 | 2.06x |
| 2022-06-07 | 2.20x |
| 2022-06-06 | 1.88x |
| 2022-06-03 | 1.86x |
| 2022-06-02 | 1.88x |
| 2022-06-01 | 1.63x |
| 2022-05-31 | 1.70x |
| 2022-05-27 | 2.04x |
| 2022-05-26 | 1.64x |
| 2022-05-25 | 1.39x |
| 2022-05-24 | 1.32x |
| 2022-05-23 | 1.66x |
| 2022-05-20 | 1.66x |
| 2022-05-19 | 1.64x |
| 2022-05-18 | 1.60x |
| 2022-05-17 | 1.69x |
| 2022-05-16 | 1.44x |
| 2022-05-13 | 1.33x |
| 2022-05-12 | 0.65x |
| 2022-05-11 | 0.52x |
| 2022-05-10 | 0.59x |
| 2022-05-09 | 0.63x |
| 2022-05-06 | 0.85x |
| 2022-05-05 | 0.97x |
| 2022-05-04 | 1.09x |
| 2022-05-03 | 0.97x |
| 2022-05-02 | 1.08x |
| 2022-04-29 | 0.93x |
| 2022-04-28 | 1.00x |
| 2022-04-27 | 0.97x |
| 2022-04-26 | 1.01x |
| 2022-04-25 | 1.20x |
| 2022-04-22 | 1.16x |
| 2022-04-21 | 1.25x |
| 2022-04-20 | 1.46x |
| 2022-04-19 | 1.51x |
| 2022-04-18 | 1.47x |
| 2022-04-14 | 1.72x |
| 2022-04-13 | 1.76x |
| 2022-04-12 | 1.67x |
| 2022-04-11 | 1.77x |
| 2022-04-08 | 1.76x |
| 2022-04-07 | 1.89x |
| 2022-04-06 | 1.88x |
| 2022-04-05 | 1.93x |
| 2022-04-04 | 2.15x |
| 2022-04-01 | 2.08x |
| 2022-03-31 | 2.08x |
| 2022-03-30 | 2.18x |
| 2022-03-29 | 2.31x |
| 2022-03-28 | 2.06x |
| 2022-03-25 | 1.81x |
| 2022-03-24 | 2.16x |
| 2022-03-23 | 2.02x |
| 2022-03-22 | 2.13x |
| 2022-03-21 | 2.09x |
| 2022-03-18 | 2.18x |
| 2022-03-17 | 2.19x |
| 2022-03-16 | 1.95x |
| 2022-03-15 | 1.69x |
| 2022-03-14 | 1.31x |
| 2022-03-11 | 1.42x |
| 2022-03-10 | 1.59x |
| 2022-03-09 | 1.66x |
| 2022-03-08 | 1.52x |
| 2022-03-07 | 1.51x |
| 2022-03-04 | 1.59x |
| 2022-03-03 | 1.70x |
| 2022-03-02 | 1.72x |
| 2022-03-01 | 1.77x |
| 2022-02-28 | 1.75x |
| 2022-02-25 | 1.71x |
| 2022-02-24 | 1.72x |
| 2022-02-23 | 1.63x |
| 2022-02-22 | 1.77x |
| 2022-02-18 | 1.93x |
| 2022-02-17 | 2.02x |
| 2022-02-16 | 2.24x |
| 2022-02-15 | 2.37x |
| 2022-02-14 | 2.18x |
| 2022-02-11 | 2.40x |
Showing the most recent 260 of 637 data points. The chart above shows the full history.
